Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Nov 2025 is 6.36% vs 3.66% in Aug 2025
Consolidate Net Profit
QoQ Growth in quarter ended Nov 2025 is -69.70% vs -19.51% in Aug 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Nov 2025 is 44.44% vs -228.57% in Aug 2025
Interest
QoQ Growth in quarter ended Nov 2025 is -22.22% vs -18.18% in Aug 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025
Compare Quarterly Results Of Cannara Biotech, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Nov 2025 is 6.36% vs 3.66% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 19.92% vs 28.72% in Nov 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Nov 2025 is -69.70% vs -19.51% in Aug 2025
YoY Growth in quarter ended Nov 2025 is -56.52% vs 9.52% in Nov 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Nov 2025 is 44.44% vs -228.57% in Aug 2025
YoY Growth in quarter ended Nov 2025 is 0.00% vs 66.67% in Nov 2024
Quarterly - Interest
QoQ Growth in quarter ended Nov 2025 is -22.22% vs -18.18% in Aug 2025
YoY Growth in quarter ended Nov 2025 is -41.67% vs -14.29% in Nov 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025
YoY Growth in quarter ended Nov 2025 has improved from Nov 2024






